Radiobiological Assessment of Targeted Radionuclide Therapy with [<sup>177</sup>Lu]Lu-PSMA-I&amp;T in 2D vs. 3D Cell Culture Models

Author(s)
Julia Raitanen, Bernadette Barta, Hermann Fuchs, Marcus Hacker, Theresa Balber, Dietmar Georg, Markus Mitterhauser
Abstract

In vitro therapeutic efficacy studies are commonly conducted in cell monolayers. However, three-dimensional (3D) tumor spheroids are known to better represent in vivo tumors. This study used [177Lu]Lu-PSMA-I&T, an already clinically applied radiopharmaceutical for targeted radionuclide therapy against metastatic castrate-resistant prostate cancer, to demonstrate the differences in the radiobiological response between 2D and 3D cell culture models of the prostate cancer cell lines PC-3 (PSMA negative) and LNCaP (PSMA positive). After assessing the target expression in both models via Western Blot, cell viability, reproductive ability, and growth inhibition were assessed. To investigate the geometric effects on dosimetry for the 2D vs. 3D models, Monte Carlo simulations were performed. Our results showed that PSMA expression in LNCaP spheroids was highly preserved, and target specificity was shown in both models. In monolayers of LNCaP, no short-term (48 h after treatment), but only long-term (14 days after treatment) radiobiological effects were evident, showing decreased viability and reproductive ability with the increasing activity. Further, LNCaP spheroid growth was inhibited with the increasing activity. Overall, treatment efficacy was higher in LNCaP spheroids compared to monolayers, which can be explained by the difference in the resulting dose, among others.

Organisation(s)
Department of Inorganic Chemistry, Joint Applied Medicinal Radiochemistry Facility
External organisation(s)
Medizinische Universität Wien, Ludwig Boltzmann Institute, Vienna Doctoral School in Chemistry (DoSChem)
Journal
International Journal of Molecular Sciences
Volume
24
ISSN
1661-6596
DOI
https://doi.org/10.3390/ijms242317015
Publication date
12-2023
Peer reviewed
Yes
Austrian Fields of Science 2012
106023 Molecular biology, 104020 Radiochemistry, 301904 Cancer research
Keywords
ASJC Scopus subject areas
Catalysis, Molecular Biology, Spectroscopy, Computer Science Applications, Physical and Theoretical Chemistry, Organic Chemistry, Inorganic Chemistry
Sustainable Development Goals
SDG 3 - Good Health and Well-being
Portal url
https://ucrisportal.univie.ac.at/en/publications/7d58e177-51a8-4a6b-9c0d-5f370c4c4772